Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate

Redox Report

Volumn 14, Issue 3, 2009, Pages 109-114

  Nakatsuka, Ichiro ^a   Maeda, Shigeru ^a   Andoh, Tsugunobu ^a   Hayashi, Yukiko ^a   Mizuno, Ryuichiro ^a   Higuchi, Hitoshi ^a   Miyawaki, Takuya ^a  

^a OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cortex; Ferric nitrilotriacetate; Heme oxygenase; Hyphothalamus; Iron; Muscarinic acetylcholine receptors; Neuronal disease

Indexed keywords

4 HYDROXYNONENAL; HEME OXYGENASE 1; INTERLEUKIN 6; IRON; MESSENGER RNA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; NITRILOTRIACETATE IRON; 4-HYDROXY-2-NONENAL; ALDEHYDE; DRUG DERIVATIVE; FERRIC ION; HEME OXYGENASE; IRON CHELATING AGENT; NITRILOTRIACETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN METABOLISM; BRAIN REGION; CONTROLLED STUDY; ENZYME INDUCTION; HYPOTHALAMUS; IRON METABOLISM; IRON TRANSPORT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; TISSUE DISTRIBUTION; ANIMAL; BRAIN; CYTOCHEMISTRY; DRUG EFFECT; GENETICS; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ALDEHYDES; ANIMALS; BRAIN; CEREBRAL CORTEX; FERRIC COMPOUNDS; HEME OXYGENASE (DECYCLIZING); HISTOCYTOCHEMISTRY; HYPOTHALAMUS; IMMUNOBLOTTING; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; IRON; IRON CHELATING AGENTS; MALE; NITRILOTRIACETIC ACID; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68949125368     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100009X392575     Document Type: Article

References (23)

1. O'Neil J, Powell L. Clinical aspects of hemochromatosis. Semin Liver Dis 2005; 25: 381-391.
2. Connor JR, Menzies SL. Relationship of iron to oligodendrocytes and myelination. Glia 1996; 17: 83-93.
3. Beard JL, Chen Q, Connor J, Jones BC. Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav 1994; 48: 621-624.
4. Li D. Effects of iron deficiency on iron distribution and gamma-aminobutyric acid (GABA) metabolism in young rat brain tissues. Hokkaido Igaku Zasshi 1998; 73: 215-225.
5. Huang X, Atwood CS, Hartshorn MA et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999; 38: 7609-7616.
6. Ong WY, Farooqui AA. Iron, neuroinflammation, and Alzheimer's disease. J Alzheimers Dis 2005; 8: 183-200, discussion 209-215.
7. Li JL, Okada S, Hamazaki S, Ebina Y, Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 1987; 47: 1867-1869.
8. Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 1979; 95: 663-673.
9. Kawabata T, Awai M, Kohno M. Generation of active oxygen species by iron nitrilotriacetate (Fe-NTA). Acta Med Okayama 1986; 40: 163-173.
10. Liu M, Okada S, Kawabata T. Radical-promoting 'free' iron level in the serumof rats treated with ferric nitrilotriacetate: Comparison with other iron chelate complexes. Acta Med Okayama 1991; 45: 401-408.
11. Langmead CJ, Austin NE, Branch CL et al. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. Br J Pharmacol 2008; 154: 1104-1115.
12. 3H]dopa in various regions of the brain. J Neurochem 1966; 13: 655-669.
13. Hill JM, Switzer 3rd RC. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984; 11: 595-603.
14. Morris CM, Kerwin JM, Edwardson JA. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 1994; 3: 267-275.
15. Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol Aging 2004; 25: 465-474
16. Kondo Y, Ogawa N, Asanuma M, Ota Z, Mori A. Regional differences in late-onset iron deposition, ferritin, transferrin, astrocyte proliferation, andmicroglial activation after transient forebrain ischemia in rat brain. J Cereb Blood Flow Metab 1995; 15: 216-226.
17. Wang XS, Ong WY, Connor JR. Increase in ferric and ferrous iron in the rat hippocampus with time after kainate-induced excitotoxic injury. Exp Brain Res 2002; 143: 137-148.
18. Maeda S, Nakatsuka I, Hayahi Y, Higuchi H, Shimada M, Miyawaki T. Heme oxygenase-1 induction in the brain during lipopolysaccharide-induced acute inflammation. Neuropsychiatr Dis Treat 2008; 4: 663-667.
19. Ryter SW, Choi AM. Heme oxygenase-1: Molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal 2002; 4: 625-632.
20. Yamaoka K, Mori S, Nomura T et al. Elevation of antioxidant potency in mice brain by low-dose X-ray irradiation and its effect on Fe-NTA-induced brain damage. Physiol Chem Phys Med NMR 2002; 34: 119-132.
21. White P, Hiley CR, Goodhardt MJ et al. Neocortical cholinergic neurons in elderly people. Lancet 1977; 1: 668-671.
22. Mancama D, Arranz MJ, Landau S, Kerwin R. Reduced expression of themuscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003; 119B: 2-6.
23. Okada S. Iron-induced tissue damage and cancer: The role of reactive oxygen species-free radicals. Pathol Int 1996; 46: 311-332.